CSIMarket


Meridian Bioscience Inc   (VIVO)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare


 

Meridian Bioscience Inc

VIVO's Financial Statements and Analysis



Meridian Bioscience Inc reported in II. Quarter net earnings per share of $0.60 an increase by 172.73 % year on year from $0.22 and decline of -1.64 % from $0.61 earned in I. Quarter (Dec 31 2020).


II. Quarter
Earnings Per Share Revenues
$ 0.6 $  85 Mill
$+0.38     +172.73 % $+28M     +48.81 %



Meridian Bioscience Inc 's Revenue rose by 48.81 % in II. Quarter (Mar 31 2021) year on year, to $85 million and declined by -8.24 % sequentially.


Meridian Bioscience Inc is Expected to report next financial results on February 04, 2022.

More on VIVO's Income Statement



Meridian Bioscience Inc 's net income of $26 million in II. Quarter increased by 181.03 % from net earnings of $9 million achieved in II. Quarter a year ago.

Sequentially net earnings fell by -1.78 % from net income of $26.78 million realized in previous quarter.

More on VIVO's Growth

Inventories grew by 76.88 % to $73 million from II. Quarter a year ago, sequentially inventories rose by 7.87 %. VIVO's Cash flow In II. Quarter company's net cash flow was $0 million, capital expenditures fell by 720.37%, to $-10 millions compare to same quarter a year ago and fell by 373.11% from I. Quarter (Dec 31 2020).

More on VIVO's Cash flow Statement


Meridian Bioscience Inc does not pay out common stock dividend.

In trailing twelve-month period Meridian Bioscience Inc earned $ 1.67 cash per share, on a free-cash flow basis 83.58 % of net earning per share.

Book value grew by 10.11 % sequentially to $7.01 per share, 112.74% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 2.61 per share from $ 1.90.

Company issued 0.34 million shares or 0.78 % in II. Quarter.
Interest Coverage Ratio was 47.99. Debt Coverage Ratio was 1.62.

More on VIVO's Dividends

 Market Capitalization (Millions) 911
 Shares Outstanding (Millions) 44
 Total Debt (Millions $) 50
 Revenue (TTM) (Millions $) 327
 Net Income (TTM) (Millions $) 87
 Cash Flow (TTM) (Millions $) 14
 Capital Exp. (TTM) (Millions $) -14
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Meridian Bioscience Inc does not pay out common stock dividend.

In trailing twelve-month period Meridian Bioscience Inc earned $ 1.67 cash per share, on a free-cash flow basis 83.58 % of net earning per share.

Book value grew by 10.11 % sequentially to $7.01 per share, 112.74% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 2.61 per share from $ 1.90.

Company issued 0.34 million shares or 0.78 % in II. Quarter.
Interest Coverage Ratio was 47.99. Debt Coverage Ratio was 1.62.

More on VIVO's Balance Sheets

 Market Capitalization (Millions) 911
 Shares Outstanding (Millions) 44
 Total Debt (Millions $) 50
 Revenue (TTM) (Millions $) 327
 Net Income (TTM) (Millions $) 87
 Cash Flow (TTM) (Millions $) 14
 Capital Exp. (TTM) (Millions $) -14
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

XSPA's Profile

Stock Price

XSPA's Financials

Business Description

Fundamentals

Charts & Quotes

XSPA's News

Suppliers

XSPA's Competitors

Customers & Markets

Economic Indicators

XSPA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071